Search results
New research platform assesses brain cancer mutati | Newswise
Newswise· 6 days agoJACKSONVILLE, Fla. — Brain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study ...
Mother backs Epsom Derby auction to honour daughter
BBC via Yahoo News· 6 days agoFunds raised by the event will be used by the charity for research at its centres across the UK, with the aim of finding a cure for brain cancer. Emily,...
Researchers create 'chameleon' compound that targets drug-resistant brain cancers
Medical Xpress· 2 days agoThe research, published in the Journal of the American Chemical Society, is a crucial step in the development of so-called "chameleon compounds" that may be used to target an array of pernicious ...
Walk six laps for Emerson the Brave, a 12-year-old battling cancer in Holland
The Holland Sentinel· 2 days ago— A walkathon next week will raise funds for a local child battling brain cancer. West Ottawa Public...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoSapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation PR Newswire TARRYTOWN, N.Y., June 1, 2024 -Data demonstrates durable responses across 3 cohorts of patients with
Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty
Zacks via Yahoo Finance· 7 days agoAgios Pharmaceuticals (AGIO) agrees to sell to Royalty Pharma the rights to royalties on potential...
Epsom Derby: Mother backs event to honour daughter
BBC News· 6 days agoA mother from Surrey is marking the fifth anniversary of her daughter’s death by supporting a charity hat auction at the Epsom Derby. Debi Oliver, a...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 2 days agoIN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies, presented encouraging preliminary clinical data of INB-200 at ...
New research platform assesses brain cancer mutations during surgery
Science Daily· 6 days agoThe platform uses mass spectrometry to identify a key gene mutation in brain cancer, known as isocitrate dehydrogenase (IDH) mutations, in real time. Mass spectrometry is a sensitive technique ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 days agoResults from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration of treatment Initial data from Phase 0/1 “trigger” (“window of